$44.84
-4.65-9.4%
가까이에: Aug 27, 5:00 PM EST
$47.26
-2.23-4.51%
프리마켓: 4:17 AM EST
Benzinga
Benzinga
Benzinga
월요일, 8월 31
Hemab Therapeutics Holdings Inc
COAGNASDAQ
Hemab Therapeutics Hldgs Earnings & Forecasts
Hemab Therapeutics Hldgs (COAG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Hemab Therapeutics Hldgs Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.78 | — |
| Actual | $-0.80 | $-23.98 |
| Surprise | -2.56% | — |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.56 | $-0.52 | $-0.49 | $-0.65 |
| Revenue | ||||
| Consensus | — | — | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved